EP ELEDON PHARMACEUTICALS Trademark

Trademark Overview

On Friday, January 8, 2021, a trademark application was filed for EP ELEDON PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the EP ELEDON PHARMACEUTICALS trademark a serial number of 90456181. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, May 6, 2025. This trademark is owned by Eledon Pharmaceuticals, Inc.. The EP ELEDON PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation

Pharmaceutical research and development and medical research and development in the field of autoimmune and neurodegenerative diseases
ep eledon pharmaceuticals

General Information

Serial Number90456181
Word MarkEP ELEDON PHARMACEUTICALS
Filing DateFriday, January 8, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, May 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Description of MarkThe mark consists of a stylized letter "E" displayed backwards and adjacent to a stylized letter "P", with the word "Eledon" above the word "Pharmaceuticals" to the right.
Goods and ServicesPharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesPharmaceutical research and development and medical research and development in the field of autoimmune and neurodegenerative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 8, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEledon Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameEledon Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Tuesday, July 27, 2021PRIORITY ACTION WRITTEN
Tuesday, January 12, 2021NEW APPLICATION ENTERED
Thursday, April 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 16, 2021ASSIGNED TO EXAMINER
Tuesday, July 27, 2021PRIORITY ACTION E-MAILED
Tuesday, July 27, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, November 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 27, 2022ASSIGNED TO LIE
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 24, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 24, 2022SOU EXTENSION 1 FILED
Monday, October 24, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 25, 2023SOU EXTENSION 2 FILED
Tuesday, April 25, 2023SOU EXTENSION 2 GRANTED
Thursday, April 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 24, 2023SOU EXTENSION 3 FILED
Tuesday, October 24, 2023SOU EXTENSION 3 GRANTED
Thursday, October 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 25, 2024SOU EXTENSION 4 FILED
Thursday, April 25, 2024SOU EXTENSION 4 GRANTED
Tuesday, October 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 22, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 22, 2024SOU EXTENSION 5 FILED
Wednesday, September 24, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, September 23, 2025ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 22, 2024SOU EXTENSION 5 GRANTED

Related Keywords

pharmaceuticals eledon neurodegenerative diseases research development pharmaceutical autoimmune targeting transplantation products medical